News
and updatesPediCAP trial findings disseminated to Mozambican healthcare community
The PediCAP trial team is pleased to announce the successful completion of a series of dissemination meetings aimed at sharing trial results with key stakeholders in Mozambique. These meetings targeted a diverse audience, including healthcare professionals,...
Four-day antibiotic treatment shows promise for childhood pneumonia in Africa
The PediCAP consortium, a global partnership of 14 institutions, presented promising results from its main trial, PediCAP-A, at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) conference held from April 27-30, 2024, in Barcelona,...
New treatment strategy could bring children with pneumonia home from hospital earlier
Summary: The PediCAP trial found that it is safe to switch children in hospital with pneumonia from injectable to oral antibiotics once their health improves. Children who are recovering from severe pneumonia could safely switch from injectable to oral antibiotics...
Advancing paediatric antibiotic research two new African-European research collaborations tackle severe infections in neonates and children
Johannesburg, South Africa, 31 January 2024 This week, expert scientists and clinicians from PediCAP and SNIP-AFRICA, two major research partnerships combatting antimicrobial resistance, convene in Johannesburg to present groundbreaking results and ways to advance...
PediCAP project at the European & Developing Countries Clinical Trials Partnership Forum
The PediCAP project, dedicated to investigating antibiotic therapy for severe and very severe childhood community-acquired pneumonia, actively participated in the European & Developing Countries Clinical Trials Partnership (EDCTP) forum held in France from Nov...
PediCAP trial completes recruitment, investigating more child-friendly treatment options for severe community-acquired pneumonia
Padova, Italy, 1 September 2023 - The PediCAP team is pleased to report that the 1100 patients required for the main trial in this study have now been recruited. PediCAP is an innovative, EDCTP funded clinical trial, using a novel durations design led by the MRC...
WHO releases first ever list of priority antibiotics
On March 23, 2023, the WHO released the first-ever list of priority antibiotics to be developed in age-appropriate formulations for children and infants. The PADO priority list includes antibiotics that are essential for treating common bacterial infections in...
Registrations are open for Penta’s AMR Online Course
We are happy to announce that registrations are now open* for Penta‘s new interactive training programme – ‘PentaTr@ining: AMR Online Course’! This timely course brings together doctors, nurses, pharmacists and other healthcare workers linked through the...
Two-thirds recruitment milestone reached for PediCAP!
We are pleased to have reached the two-thirds recruitment milestone with more than 750 children admitted to hospital with severe or very severe pneumonia, now recruited into the PediCAP trial. The last couple of years have been particularly challenging for our trial...
PediCAP has reached the 50% recruitment milestone
The PediCAP consortium is pleased to announce a major milestone. Site teams in Uganda, Zambia, Zimbabwe and South Africa have successfully reached 50% recruitment of the PediCAP trial. Of the 1100 expected participants of children hospitalised with severe or very...